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From 1978 to 1988, coronary angioplasty was performed in
422 patients with prior coronary artery bypass surgery (264
patients with native coronary artery angioplasty and 158
patients with graft angioplasty). Angioplasty was successful
in 84%, unsuccessful but uncomplicated in 11 % and com·
plicated by one or more major cardiac events in 5%
(myocardial infarction 5%, emergency bypass surgery 2%
and death 0.2%). Follow-up data were obtained in 99% of
356 patients with successful angioplasty. At a mean of 33 ±
26 months, 92% were alive, 73% had improvement in
angina and 61 % were free of angina. One or more of the
following late events occurred in 67 patients (19%): myo-
cardial infarction (6%), elective reoperation (13%) and
cardiac death (6%). Repeat angioplasty was performed in
27%, with a success rate of 89% and no deaths.
Initial success rates were equal in native vessel versus
graft angioplasty, but late outcome was less favorable with
the latter because of a higher rate of infarction (11 % versus
4%, p < 0.05) and need for reoperation (19% versus 10%,
p < 0.05). The initial success rate was higher in vein grafts
<1 year old compared with grafts 1 to 4 years or >4 years
after operation (92% versus 85% versus 83%, respectively)
Although symptomatic relief after coronary artery bypass
graft surgery is common, angina frequently recurs in subse-
quent years. Recurrence of ischemia may be due to graft
failure, progression of disease in native coronary arteries or
incomplete initial revascularization. Asecond operation may
be required in 7% to 12% of patients after 10 years (\-3).
Reoperation carries a significantly higher risk than the
initial procedure. One experienced center (I) reported a
> lO-fold increase in perioperative infarction and a Hold
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and adverse late events were less frequent after angioplasty
in recent vein grafts « 1 year 13%, 1 to 4 years 35 %, >4
years 29%; <1 versus >1 year, p < 0.05).
The initial angioplasty success rate was higher with
distal anastomotic vein graft sites (89%) than with midshaft
(86%) or proximal (80%) anastomotic sites. There was a
similar trend for late restenosis (distal 40%, midshaft 46%,
proximal 60 %). Other predictors of restenosis included
smoking (p < 0.01) and male gender (p < 0.05).
Although coronary angioplasty can be performed with
high initial success, low morbidity and very low mortality
rates in patients with prior coronary bypass surgery, repeat
angioplasty for restenosis or disease progression was nec-
essary in 27%. After successful angioplasty, life table
analysis showed an actuarial 5 year survival rate of 89 %
and freedom from death, infarction or repeat bypass sur-
gery in 71 %. Predictors of late death or infarction included
prior infarction (p < 0.05), unstable angina (p < 0.05),
multivessel disease (p < 0.05) and left ventricular ejection
fraction <25% (p < 0.01).
(J Am CoLL CardioI1990;16:812-20)
increase in the incidence of death associated with reopera-
tion. Recent surgical series (\-5) have reported a perioper-
ative mortality rate of 3.4% to 9.2% associated with a second
coronary bypass operation (\-4) (Table I) and a 12% mor-
tality rate associated with a third operation (5). Symptomatic
improvement occurred in 60% to 80% of patients undergoing
reoperation compared with >90% after the initial operation.
After reoperation, <50% of the patients remained free of
angina at late follow-up study, with a 5 year survival rate of
75% to 86% (\ ,3-5),
Until recently, relatively few patients were considered
candidates for coronary angioplasty when symptoms re-
curred after prior coronary bypass surgery (6). An early
study (7) reported a higher complication rate for angioplasty
in patients with than in patients without prior coronary
bypass surgery. However, recent reports (8-13) have shown
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Table 1. Reported Initial Outcome of a Second Coronary Artery
Bypass Operation
No. of Grafts! Death
Authors (reD Year Patients Patient MI(%) (%)
Hall et al. (4) 1986 958 2.7 9.2
Laird-Meeter et al. (2) 1987 99 2.6 6.5
Lytle et al. (1) 1987 1.500 2.1 7.2 3.4
Cameron et al. (3) 1988 64 1.9 4.7
Total 2,621 2,3 7.2 5.6
MI '" myocardial infarction: ref'" reference number.
a more salutary trend and patients with prior bypass surgery
now represent a major group in which angioplasty is utilized,
We review the largest reported experience with angio-
plasty in patients with prior coronary artery bypass surgery
and describe the early and the late outcome of angioplasty in
this cohort.
Methods
Data acquisition. All patients with prior coronary artery
bypass surgery (at this institution or elsewhere) who subse-
quently had native coronary or graft angioplasty performed
at this institution between March 1978 and December 1988
were included in the study, Data were obtained from an
ongoing computerized data base as well as medical and
catheterization laboratory records, Follow-up data were
obtained from medical records and by contacting patients or
their referring physicians, or both, within 1 month and at 6
month intervals after the procedure, Angiographic measure-
ments before and after angioplasty were obtained by aver-
aging orthogonal projections from the cineangiogram utiliz-
ing a programmable digital caliper (12,14),
Patient profiles. Angioplasty was attempted in 422 pa-
tients with prior coronary artery bypass surgery, The mean
patient age was 60,6 years (range 28 to 87) and the average
period between bypass surgery and angioplasty was 66
months (range 1 to 214), The majority of patients were
limited by angina (75% were in Canadian Cardiovascular
Society functional class 1lI or IV) (15) and 43% had had a
recent acceleration in symptoms (unstable angina). The
mean diameter stenosis was 75 ± 13%, The angiographic left
ventricular ejection fraction (obtained in 399 patients) was
<45% in half of the patients. Additional clinical data are
presented in Table 2.
Angioplasty procedure. Angioplasty was performed on
native coronary arteries alone in 264 of the 422 patients
(Group I), Angioplasty of a graft conduit was performed in
158 patients (Group II), of whom 140 had at least one
saphenous vein dilated and 18 had internal mammary artery
angioplasty, Among these 158 patients with graft angio-
piasty , 41 also had a native coronary artery dilated,
Native coronary artery angioplasty involved the left main
Table 2. Clinical Profile of 422 Patients Undergoing Angioplasty
After Prior Coronary Artery Bypass Surgery
Patients
No, %
Men 332 79
Women 90 21
Hypertension 190 45
Diabetes 76 18
Smoking status
Former 249 59
Current 46 11
Prior M1 236 56
Anginal class'
I 0 0
II 106 25
III 236 56
IV 80 19
SVD 114 27
DVD 153 36
TVD 155 37
LVEF
<25% 12 3
25%-34% 25 6
35%_45% 163 41
>45% 199 50
•According to the Canadian Cardiovascular Society classification.
DVD = double vessel disease: LVEF = left ventricular ejection fraction:
MI = myocardial infarction: SVD '" single vessel disease: TVD '" triple
vessel disease.
stem in 17 patients, left anterior descending artery in 101, left
circumflex artery in 105, right coronary artery in 110, diag-
onal branch in 20, obtuse marginal branch in 47 and a ramus
intermedius in 4, The lesions included totally occluded
vessels in 24 patients, bifurcated lesions in 12 and long (> 10
mm) or tandem lesions in 146. Angioplasty was attempted in
a single vessel in 70% and in multiple vessels in 30% of
patients, The number of vessels dilated was 1in 302 patients,
2 in 10 I, 3 in 17 and 4 in 2, with an average of 1.4 native
arteries per patient or, overall, 1,3 vessels (including grafts)
per patient.
Indications. Patients who had return of significant angina
in the months or years after coronary bypass surgery and in
whom coronary angiography revealed lesions amenable to
angioplasty were selected for study. These morphologic
indications evolved during the period of this study (1978 to
1988) and are reported elsewhere (16). Age, gender, anginal
class and left ventricular function were not reasons for
exclusion.
Definitions of terms. The following definitions were used.
Procedural success: a 2:35% reduction in percent diam-
eter stenosis with a postangioplasty residual stenosis <50%
and no major cardiac event (14),
Major cardiac event: occurrence of one or more of the
following events: need for emergency coronary artery by-
pass surgery, myocardial infarction or death (14).
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*Introduction of improved guiding catheters; tintroduction of steerable
guide wires; tmore complex cases. See Methods for definitions of terms.
anginal class, number of diseased vessels and left ventricular
ejection fraction) did not differ significantly from that in the
group with successful angioplasty. Unsuccessful but uncom-
plicated angioplasty was due to inability to position the
balloon across the lesion in 21 patients (46%), traverse the
lesion with a guide wire in 12 (26%), cannulate the target
vessel in 2 (4%), dilate a calcified lesion in 1 (2%) and
decrease percent diameter stenosis by >35% in 10 (22%).
One or more major cardiac events (myocardial infarction,
emergency coronary bypass surgery or death) occurred in 20
patients (5%). Emergency bypass surgery was necessary in
10 patients (2%), of whom 4 had perioperative infarction. In
addition. 9 patients sustained myocardial infarction, but did
not have surgery; the total number of patients with myocar-
dial infarction was 13 (3%). The one procedure-related death
(0.2%) occurred in 1979.
During the 10 year period encompassed by this study,
there was an increase in the frequency of angioplasty in
patients with prior coronary bypass surgery. Angioplasty
success rates improved during this period, although in the
most recent era (1986 to 1988), with cases of increased
complexity. a less favorable initial outcome was observed
(Table 3).
The average hospital stay in this patient cohort was 4.5
days. At discharge and in the early follow-up period, symp-
toms were improved or resolved in 377 patients (89%),
unchanged in 38 (9%) and worse in 5 (1%).
Native coronary artery angioplasty. Group I (264 patients)
had angiopiasty of one or more native coronary arteries
alone. Success was achieved in 225 patients (85%) and 293
(84%) of 348 vessels. Angioplasty was unsuccessful but
uncomplicated in 28 patients (11 %) and complicated by a
major cardiac event in 11 patients (4%), including the one
patient who died (0.2%). Seventeen patients had dilation of a
left main stem stenosis (all 17 protected by at least one
patent left coronary graft), with success in 16 (94%).
Graft angioplasty. Group 11 (158 patients) had angio-
plasty of a saphenous vein or internal mammary artery
bypass graft. Success was achieved in 83% of patients.
Table 3. Coronary Angioplasty After Prior Coronary
Bypass Surgery in Patients During Different Eras (San
Francisco Heart Institute)
7.1
16.7
2.6
5.0
4.7
Major
Cardiac
Event (%)
35.7
16.7
7.9
10.5
10.9
Unsuccessful!
Uncomplicated (%)
14 57.1
18 66.7
151 89.4
239 84.5
422 84.4
No. of Procedural
Patients Success (%)Era
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1983-1985t
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Total
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I 20 (4.7%1 1 • QMI ONLY
9 (2.1~1
• EmCA8G ONLY
6 (1.4~1
QMI • EmCA8G
4 (O.9~1
.,.1 DEATH
1 (0.2%1
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I 46 (10.9%11
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13156 (64.4%11
Initial Outcome
Coronary angioplasty was successful in 356 (84%) of the
422 patients (Fig. I) and in 475 (84%) of 563 vessels at-
tempted. Mean diameter stenosis was reduced from 75 ±
13% to 29 ± 22%.
Angioplasty was unsuccessful but uncomplicated in 46
patients (ll%).Compared with the group with a successful
procedure, this group had a higher mean diameter stenosis
before angioplasty (86 ± 10% versus 74 ± 13%, p < 0.01)
and were more likely to have a totally occluded artery (15%
versus 5%, p < 0.01). Their clinical profile (age, gender,
diabetes, hypertension, cholesterol level, smoking status,
Results
Figure 1. Early outcome after coronary angioplasty in 422 patients
with prior coronary artery bypass surgery (see Methods for defini-
tions of terms). Ten patients (2.4%) underwent emergency coronary
artery bypass surgery (EmCABG) and 13 (3.1%) had Q wave
myocardial infarction (QMIl.
Unsuccessful but uncomplicated procedure: one in
which success was not obtained but without a major cardiac
event.
Restenosis: loss of ~50% of the luminal diameter gain at
the site of initial successful angioplasty.
Groups I and II: Group I patients had angioplasty of a
native coronary artery alone (in which grafts had either
failed or not been placed); Group II patients had angioplasty
of either a saphenous vein or internal mammary graft (with
or without angioplasty of a native coronary artery).
Statistical analysis. Continuous variables are expressed
as mean values ± SD. Student's t tests were performed to
determine significant differences between mean values. Chi-
square analyses or Fisher's exact tests were used to compare
categoric variables. Life table analyses were performed by
the Kaplan-Meier method (17). Multivariate logistic regres-
sion analyses were used to assess factors predicting out-
come. Differences were accepted as significant at p < 0.05.
Analyses were performed on a MicroVax II computer using
SPSSX and BMDP statistical software.
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Table 4. Early and Late (mean 30 months) Results After
Saphenous Vein Graft Angioplasty in 140 Patients: Graft Age
Versus Outcome
'Events not mutually exclusive; tineidenee statistically different (p <
0.05) from both other values. CABG =coronary artery bypass surgery; MI =
myocardial infarction; uncomp = uncomplicated.
26 27 87 140
92.3 85.1 82.8 85
3.8 14.9 9.2 9.3
3.8 0 8 5.7
0 0 0 0
24 23 72 119
Vein Graft Age
obtained in 85% of vein graft sites; it was lowest for proximal
sites (80%), higher for midgraft sites (86%) and highest for
distal sites (89%). The site of vein graft stenosis (and
therefore angioplasty) was usually either the proximal or the
distal anastomosis in new « 1 year old) grafts; older grafts
were more likely to have stenosis in proximal or midgraft
sites. Recanalization of six chronically occluded grafts was
attempted and was successful in three and unsuccessful but
uncomplicated in three.
Internal mammary artery graft angioplasty was per-
formed in 18 patients. The average age of the internal
mammary graft was 8.8 months (range 7 days to 28 months)
and in all cases the stenosis involved the distal anastomosis.
Angioplasty was successful in 12 patients and unsuccessful
but uncomplicated in 5. The major cause of failure was
inability to cross the tight distal anastomosis of a very
tortuous graft. Abrupt occlusion caused by guiding catheter
dissection of the proximal graft resulted in uncomplicated
emergency bypass surgery in one patient.
10.9
18.5
7.6
26.9
Total
15.3
18.1
8.3
29.1
8.7
26.1
13.0
34.8
ot
12.5
ot
12.5t
<I Year 1-4 Years >4 Years
No. of patients
Initial outcome (%)
Procedural success
Unsuccessful/uncomp
MI or CABG
Death
No. of patients
Late outcome of
successful
angioplasty (%)
MI'
CABG'
Cardiac death'
MI. CABG or
cardiac death
Angioplasty was unsuccessful but uncomplicated in 11% and
complicated by a major cardiac event in 6%. There were no
deaths.
Angioplasty was performed at 168 sites in 148 saphenous
vein grafts in 140 patients (Tables 4 and 5). Success was
obtained in 119 patients (85%). Angioplasty was unsuccess-
ful but uncomplicated in 13 patients (9%). A major cardiac
event occurred in eight patients (6%), of whom six (4%) had
myocardial infarction and two (I %) required emergency
bypass surgery; there were no deaths in this cohort. The
angioplasty site involved the proximal vein graft (including
aortic anastomosis) in 35%, the midportion of the graft in
27% and the distal anastomotic site in 38%. Success was
Late Outcome After Successful Angioplasty.
Follow-up data were obtained in 351 (99%) of the 356
patients with successful angioplasty. At a mean of 33 ± 26
months, 321 (92%) were alive, 73% had improvement in
anginal status and 61 % were free of angina. Sixty-seven
patients (19%) had one or more late cardiac events. Specif-
ically, 22 patients (6%) had late myocardial infarction and 44
(13%) required repeat elective coronary bypass surgery.
There were 30 late deaths, of which 20 (6%) were cardiac
related. After successful angioplasty, late infarction and
repeat coronary bypass surgery were significantly more
frequent in patients who had a graft dilated (Group II) than in
patients who had only native coronary arteries dilated
(Group I). Yet, late survival, anginal status and the need for
Table 5. Initial Success of Angioplasty in 168 Vein Graft Sites (\48 vein grafts in 140 patients): Graft Site Versus Graft Age and
Procedural Success
Graft Age
<I Year 1-4 Years >4 Years Total
No. (%) No. 1%) No. (%) No. 1%)
Location of graft stenosis
Proximal 10 (17) 7 112) 42 (71 ) 59 (100)
Mid 4 (9) 6 (13) 35 (78) 45 (100)
Distal 19 (30) 18 (28) 27 (42) 64 (100)
Total 33 (20) 31 (18) 104 (62) 168 (100)
Initial outcome (success)
Proximal 8 (80) 5 (71) 34 (81) 47 (80)
Mid 4 (100) 5 (83) 30 (86) 39 (86)
Distal 16 (84) 16 (89) 24 (89) 56 (89)
Total 28 (88) 26 (84) 88 (85) 142 (84.5)
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Table 6. Late Outcome After Successful Angioplasty in 351 Table 7. Predictors of Late Death and Myocardial Infarction After
Patients With Prior Coronary Bypass Surgery Successful Coronary Angioplasty in 351 Patients With Prior
Group I Group II Total p Value
Coronary Bypass Surgery
Patients (no.) 221 130 351
Analysis
Follow-up duration (months) 34 :!: 28 30 :!: 21 33 :!: 26 NS Predictors Univariate Multivariate
Survival (%) 91.4 91.5 91.5 NS
Angina-free (%) 60.2 62.3 61.0 NS
Late death (n = 30)
Repeat angioplasty (%) 28.5 23.1 26.5 NS
Prior MI <0.05 <0.05
Late CABG (%) 10.0 16.9 12.5 <0.05
Unstable angina <0.01 <0.05
Late MI (%) 4.1 10.0 6.3 <0.05
LVEF <25% <0.001 <0.01
Late death (%) Class IV angina <0.05
Cardiac 5.0 6.9 5.7 NS
Age >64 yr <0.05
Noncardiac 3.6 1.5 2.8 NS
Late death or MI (n = 52)
Late MI, CABG or cardiac 15.5 23.7 19.1 <0.05
Unstable angina <0.05 <0.05
death (%1 No. of diseased vessels <0.05 <0.05
LVEF <25% <0.05 <0.01
P value = comparison of Groups I and II. Abbreviations as in Table 4.
Abbreviations as in Table 2.
100
Figure 2. Late outcome after successful coronary angioplasty in
patients with prior coronary artery bypass surgery (CABG) (Kaplan-
Meier life table analysis [17]), MI = myocardial infarction.
noted in 32 patients and restenosis was documented in 107.
In this select cohort, restenosis in 74 (41%) of 182 native
coronary arteries and 38 (50%) of 76 vein grafts was docu-
mented. Within the vein graft group. stenosis of proximal
sites was most likely to recur (60%), followed by graft body
sites (46%) and distal anastomotic sites (40%).
Factors predictive of restenosis were current smoking
(p < 0,01). male gender (p < 0.05) and graft site (p < 0.05) by
univariate analysis and current smoking (p < 0.01) and graft
site (p < 0.05) by multivariate analysis. Age, diabetes,
hypertension. hypercholesterolemia and anginal class were
not statistically significant predictors of restenosis in this
study.
A second angioplasty procedure was performed in 93
patients (27%) with initially successful angioplasty because
of restenosis or disease progression (new stenosis). Repeat
angioplasty was successful in 83 patients (89%), unsuccess-
ful but uncomplicated in 6 (7%) and associated with myocar-
dial infarction or emergency bypass surgery in 4 (4%). There
were no deaths associated with repeat angioplasty.
Late elective reoperation for stenosis or disease progres-
sion was performed in 44 patients with initially successful
angioplasty and was associated with perioperative nonfatal
infarction in 7 (16%). An additional reoperative case had a
late (medical) nonfatal infarction. There were five perioper-
ative (in-hospital) deaths (11%) associated with reoperation
and three later (medical) deaths in this group with repeat
operation, Freedom from death or myocardial infarction in
this elective reoperation cohort was 64%,
Late Outcome After Unsuccessful Angioplasty.
Of the 46 patients with unsuccessful but uncomplicated
angioplasty, 38 had elective reoperation, often within a few
days of the angioplasty attempt and usually by the original
surgeons in their hospital of origin. There were four opera-
6 7
--~-~_.~~-- -- ,-----------,
1 2 3 4 5
TIME (YEARS)
--.-. DEATH
~~. DEATH OR MI
~ DEATH, MI, OR
CABG
50
o
repeat angioplasty were not significantly different in patients
having graft or native vessel angioplasty (Table 6).
Life table analysis. Kaplan-Meier life table analysis re-
vealed an actuarial survival rate of 89% at 5 years (17). The
rate for freedom from death and infarction was 83% and for
freedom from death. infarction and surgery 71% at 5 years
(Fig. 2).
Predictors of late outcome. The factors predictive of late
death were prior infarction, unstable or class IV angina, age
>64 years, left ventricular ejection fraction <25% by
univariate analysis and prior infarction, unstable angina and
ejection fraction <25% by multivariate analysis. Late death
or infarction was positively correlated with the number of
diseased vessels, unstable angina and ejection fraction
<25% (Table 7).
Recurrence of stenosis. Follow-up angiography (mean II
± 12 months) usually to assess symptoms or an abnormal
exercise study was performed in 189 (54%) of 351 patients
with successful angioplasty. A significant new stenosis was
lACC Vol. 16, No.4
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Table 8. Reported Initial Outcome of Coronary Angioplasty in Patients With Prior Coronary Artery Bypass Surgery
No. of Success Major Cardiac MI EmCABG Death
Authors (reD Year Patients (%) Event (o/cl (o/c) (%) (%l
Douglas et al. (8) 1983 116 88 2.6 0.8 2.6 0.0
Dorros et al. (9) 1984 61 76 8.2 4.9 1.6 3.3
Corbelli et al. (10) 1985 94 88 6.4 3.2 4.3 1.1
Ernst et al. (11) 1987 83 83 2.2 2.4 0.0 0.0
Pinkerton et al. (13) 1988 236 91 3.4 3.0 3.0 0.4
Present series 1989 422 84 4.7 3.1 2.4 0.2
Total 1.012 86 4.3 2.9 2.5 0.5
EmCABG = emergency coronary artery bypass surgery; Major Cardiac Event = myocardial infarction (MI). emergency surgery or death (events not mutually
exclusive); ref = reference number.
tive deaths (11%). Late (mean 33 months) follow-up evalu-
ation revealed two additional cardiac deaths; the total death
rate for this small cohort was 13%. In those patients who
initially survived coronary bypass surgery, the survival rate
at late follow-up study was 94% and nonfatal myocardial
infarction occurred in four patients (9%).
Discussion
In recent years, symptomatic patients with prior coronary
artery bypass surgery have been increasingly referred for
subsequent revascularization by angioplasty. There was a
significant improvement in the initial outcome from the 1978
to 1982 era to 1984 to 1985 because of improvement in
technology and increased experience. As cases became
more complex (1986 to 1988), the incidence of favorable
outcome slightly declined. This may be analogous to the
results of reoperation reported from the Cleveland Clinic (I),
in which the operative mortality rate was 5% during 1967 to
1978,2% during 1979 to 1981 and 3% during 1982 to 1984.
Comparison with other postbypass angioplasty studies.
Overall, in our experience, angioplasty was successful in
84% of cases, with 95% of patients avoiding procedure-
related myocardial infarction, emergency bypass surgery or
death. These results are comparable with other studies
(8-11,13) of patients with prior coronary bypass surgery in
whom angioplasty was successful in 76% to 91% with a
relatively low incidence of major cardiac events (Table 8).
Comparison with reoperation. There is no randomized
trial of reoperation versus angioplasty for restenosis or new
stenosis in patients with prior coronary bypass surgery.
Although there are concurrent reports, risk profiles may
differ. When our angioplasty study is compared with a large
reoperation series from the Cleveland Clinic (1), certain
similarities and differences emerge. Patients undergoing re-
operation were slightly younger (mean 57 versus 60 years),
more often were men (86% versus 79%) and had a higher
incidence of left main stenosis (21 % versus 4%) and a longer
interprocedural interval (mean 79 versus 66 months). There
were an average of 2.4 grafts/patient with reoperation com-
pared with 1.3 vessels dilated/patient with angioplasty. Left
ventricular function was moderately or severely depressed
in 30% of the reoperation series versus 50% in this angio-
plasty study. The incidences of hypertension, diabetes,
hypercholesterolemia, smoking, anginal class and prior myo-
cardial infarction at the time of reoperation were not avail-
able in the surgical report (I), but were analyzed for outcome
prediction (see later in this discussion).
In the reoperation series (1) during the 1979 to 1984 era,
reasons for repeat surgery were progression of atheroscle-
rosis in native arteries in 21%, graft failure in 41% or both in
38%. In our angioplasty study. 62% had dilation of native
coronary arteries, 28% had dilation of grafts and 10% had
dilation of both.
Early mortality. Of the 54 in-hospital deaths (3.4%) that
occurred after reoperation in the surgical study (1), 74%
were considered cardiac deaths. Variables influencing peri-
operative mortality included left main stenosis, functional
class III or IV and age >60 years. Mortality was not
influenced (statistically) by the number of diseased vessels
(excluding left main), hypertension, hyperlipidemia, smok-
ing or prior infarction.
In our angioplasty study, there was one procedural death
(0.2%) and no patient with repeat angioplasty died. Patients
with unsuccessful but uncomplicated angioplasty and those
with restenosis after successful angioplasty who later under-
went elective reoperation (in various hospitals) had an
operative mortality rate of 11%. These results are threefold
higher than those from the Cleveland Clinic (1), but only
slightly higher than those reported from another major
surgical center (4).
Late mortality. In the Cleveland Clinic reoperation series
(1) during the follow-up period (mean 54 months), there were
165 late deaths (11%), with a 90% 5 year and 75% 10 year
survival rate. Thirty-seven patients (3%) required a third
operation and 84 patients (6%) had late myocardial infarc-
tion. The 5 year event-free rate of survival (no reoperation,
late myocardial infarction or return of class III or IV angina)
was 76%. Predictors of decreased late survival after reoper-
ation were age, left ventricular function, hypertension, num-
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ber of diseased coronary arteries and diabetes by univariate
analysis and age, hypertension and left ventricular function
by multivariate analysis.
By comparison, after successful angioplasty (mean 33
months), there were 30 late deaths (9%), of which 20 (6%)
were cardiac in origin; late infarction occurred in 6% and
elective reoperation in 13%, with one or more of these
occurring in 19%. At 5 years, there was an actuarial 89%
survival rate, with freedom from death or infarction in 83%
and freedom from death, infarction or need for repeat
surgery in 71%. However, an additional 93 patients (27%)
required repeat angioplasty (for restenosis or disease pro-
gression), reducing the 5 year event-free survival (no infarc-
tion, reoperation, repeat angioplasty or return of class III or
IV angina) rate to 59%. Although the need for repeat
angioplasty significantly diminished the event-free survival
rate, there was no mortality with this third procedure com-
pared with the reported 12% mortality rate associated with a
third operation (5). Predictors of adverse late outcome in
patients with repeat angioplasty were prior infarction, unsta-
ble or class IV angina, age >64 years, left ventricular
ejection fraction <25% and number of diseased vessels
(Table 7).
Native vessel angioplasty. An earlier study from this in-
stitution (14) reported the results of multivessel angioplasty
in patients who for the most part had not undergone prior
bypass surgery. The success rate (93%) was higher than that
reported here for native vessel angioplasty (85%). Also, in
the previous study, major cardiac events were less common
and the late survival rate was higher. These differences may
reflect more extensive disease in patients with prior coro-
nary bypass surgery.
Unprotected left main coronary artery lesions are a
contraindication to angioplasty. In this series, 17 patients
had angioplasty of a left main coronary artery protected by a
patent bypass graft, with initial success in 16 (94%) and with
no in-hospital death or infarction. Previous reports (18,19)
suggest that when adequately protected by a patent graft to
the left coronary system, dilation of a left main lesion can be
performed at low risk and with reasonable long-term results.
Graft angioplasty. The attrition rate of saphenous vein
grafts has been documented in several studies (20-22). The
rate of graft failure in the 1st postoperative year is between
15% and 20%; few grafts are free of disease by II years after
surgery. Patency of grafts placed at reoperation is affected
by risk factors for atherosclerosis (20), administration of
antiplatelet agents (23), use of internal mammary artery
conduits (24) and technical factors.
The age of a vein graft at the time of angioplasty may
influence the likelihood of primary success and restenosis
(ll,12). Graft failure within the 1st postoperative month is
usually related to technical factors. In contrast, stenosis that
appears I or 2 years after surgery usually represents intimal
thickening and fibrosis. The mechanism of angioplasty in
such a lesion may be stretching of the graft wall (25-27). Our
present study demonstrates a high initial success rate in
these newer grafts. Stenosis in these grafts often involved
the distal anastomosis.
Three to 4 years after surgery, atherosclerosis develops
and the mechanism of dilation is more likely to be plaque
disruption (25). Angioplasty of a lesion in the shaft of an old
diffusely diseased vein graft may lead to disruption or distal
embolization (12,25,28). In 1982, in an earlier report from
this institution (12), we described embolization after angio-
plasty of an old diffusely diseased saphenous vein graft with
numerous intraluminal filling defects. During emergency
surgery in this patient, atheroemboli were removed from the
recipient coronary artery. Examination of the old graft
showed extensive and friable atherosclerotic and thrombotic
material. Subsequently, we avoided grafts with diffuse dis-
ease or thrombi, or both. A recent report (29) underscored
these cautions. Nevertheless, 62% of the grafts in the
present, more extensive study were >4 years old. Initial
success and late clinical outcome were similar in patients
with grafts I to 4 years old and those >4 years old. This may
indicate that extended age of a vein graft itself may not be a
definite contraindication provided the stenosis is relatively
discrete and diffuse disease and thrombi are not evident on
angiography. Although angioplasty of selected older vein
grafts is associated with a fairly high initial success rate, the
results are less favorable than with grafts < 1 year old.
The specific location ofa stenosis within a vein graft is an
important determinant of outcome (30). Distal graft anasto-
motic stenosis may be associated with plaque in the recipient
coronary artery or fibrointimal hyperplasia; proximal anas-
tomotic stenosis may involve the thick elastic aortic wall,
and graft body stenosis is often composed of friable athero-
sclerotic plaque (25-27). Our study supports the findings (30)
that angioplasty success is higher and stenosis recurrence
lower with distal anastomotic lesions, intermediate with
graft body lesions and least favorable with proximal anasto-
motic lesions.
Most reports (8,9,12,13,28,30-32) of vein graft angio-
plasty have indicated an initial success rate ranging from
78% to 100%, consistent with the 85% success rate in our
study. A summary of prior reports (30) described a cumula-
tive incidence rate of 0.3% for death, 3.2% for infarction and
1.3% for emergency cardiac surgery, similar to our rate of
0%, 4.3% and 1.4%, respectively.
In this study, graft angioplasty had a slightly higher
incidence of an early adverse cardiac event than did native
coronary angioplasty. However, late outcome was signifi-
cantly less favorable after graft angioplasty because of
higher rates of restenosis, new coronary artery stenosis, late
myocardial infarction and the need for repeat bypass sur-
gery.
Failure of internal mammary grafts is rarely a result of
atherosclerotic disease »'ithin the graft itself and is more
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often the result of technical factors involving the distal
anastomosis with the native coronary artery (12,33-36). The
average age of the internal mammary graft in our series was
<9 months and the stenosis always involved the distal
anastomosis. Successful angioplasty of an internal mammary
insertional stenosis may obviate the need for reoperation and
preserve a graft that has the potential for excellent long-term
patency (24,33). Particular care must be exercised in cannu-
lating the fragile origin of internal mammary grafts (34-36).
Recurrent stenosis. The true incidence of recurrent ste-
nosis is not well documented largely because of incomplete
angiographic follow-up data (14,37). In one study (38) with 6
month angiographic follow-up information in >90% of pa-
tients undergoing multivessel angioplasty, recurrence was
documented in 23% of lesions and 34% of patients. Late (>6
months) restenosis after angioplasty is unusual in native
coronary arteries (37,39-41). Whether this 6 month "win-
dow of restenosis" is valid for vein grafts is not known; it
may be considerably longer.
In our series, restenosis of some or all dilated vessels
after successful angioplasty was documented in 57% of
patients who had repeat angioplasty performed because of
recurrent symptoms. This represents 31 %of the entire study
group. If angiographic follow-up was complete and included
those asymptomatic patients with a negative stress test, the
true incidence rate of restenosis would probably lie some-
where between 31 % and 57%. Reported restenosis rates
after graft angioplasty have ranged from 23% to 58%
(9,12,28,30-32). Obviously, restenosis is a very significant
problem, particularly in older vein grafts often encountered
in patients with prior coronary bypass surgery.
Conclusion
Coronary bypass surgery has been shown to provide
excellent symptomatic relief and in certain subgroups may
prolong life. However, the results of reoperation are less
satisfactory. This study demonstrates that coronary angio-
plasty can be performed with a high initial success rate, low
morbidity and very low mortality in patients with prior
coronary bypass surgery, although restenosis, particularly of
vein grafts, remains a problem. Initial risk and late survival
in selected patients with prior surgery compare favorably
with reports of reoperation, but recurrence of stenosis after
angioplasty significantly compromises event-free survival.
Satisfactory long-term results are more likely when angio-
plasty is directed at native vessels, newer vein grafts, distal
anastomotic sites or internal mammary artery grafts.
Currently, selected patients with prior coronary bypass
surgery and markedly depressed left ventricular function (at
high risk for reoperationj may undergo coronary angioplasty
with cardiopulmonary support (42,43), perhaps with adjunc-
tive use of the perfusion balloon angioplasty catheter (44).
Initial results are promising (here and elsewhere); long-term
outcome is pending. In addition, newer techniques for treat-
ment of saphenous vein grafts are under investigation,
including prolonged urokinase infusion (45), endovascular
prostheses (46,47), atherectomy (48,49) and laser therapy
(50,51). The results of these interventions and their effect on
restenosis are uncertain at this time, but if favorable may
significantly affect early and late outcome of coronary an-
gioplasty in patients with prior coronary bypass surgery.
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